Stockreport

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com